Barbara-Jean Anne Bormann-Kennedy, director at Xeris Biopharma Holdings, Inc. ($XERS), sold shares once on the open market in the last year for about $106,400. Her latest sale occurred on December 12, 2025. This ranks her 9,472nd among 11,678 insiders by sales value, well below the average of $8.6 million over roughly 6.4 transactions. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 12, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | S | Common Stock | 15000 | $7.09 | 142,500.0000 | 177,617,307 | 9.52% | 0.01% |
| June 4, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | A | Common Stock | 50000 | $0.00 | 157,500.0000 | 146,772,758 | 46.51% | 0.03% |
| June 5, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | A | Common Stock | 50000 | $0.00 | 107,500.0000 | 137,674,857 | 86.96% | 0.04% |